Big news dropped for diabetics this week. The U.S. Food and Drug Administration (FDA) has approved three new medications to help control blood sugar in adults with type 2 diabetes.
The FDA press release specifically stated that these three new treatments – Nesina, Kazana, and Oseni – are to be used with diet and exercise to manage blood sugar. Alogliptin is a new active ingredient found in these treatments.
“These new approvals are what I like to call ‘piggy-back’ drugs. They will reap the rewards of their predecessors like Byetta, Januvia and Victoza,” commented our resident pharmacist, Dr. Sarah G. Khan. She explained that these new drugs give patients more options. For instance, patients could receive discount cards to try the new drugs, it may force insurance companies to prefer the older drugs, or if a patient hasn’t found success with one of those they may with the new drugs. (more…)
As the American Diabetes Association encourages us to focus on diabetes this month, it’s important to understand just how prevalent it is in our country and get an idea of what a diabetic lives with on a daily basis. Furthermore, it’s also important to look at the cost of this growing disease and try to understand what can be done to change the upward trend of diagnosis.
The most recent assessment was released in 2011. The American Diabetes Association, The National Institutes of Health, and the Centers for Disease Control completed a comprehensive report describing the impact of diabetes in the United States during 2007. Since the report, the numbers have continued to climb.
The data found that 25.8 million children and adults in the United States have diabetes; or 8.3 percent of the population. These stats do not breakout the difference between the two kinds of diabetes, type I and type II.
More than 230,000 death certificates in 2007 had diabetes listed as the contributing factor for the death. Those who have diabetes are most susceptible to conditions like heart disease, stroke, hypertension, kidney disease, blindness, and amputation.
Nearly $175 billion was spent in 2007 to cover all the costs of diabetes. These expenses included direct medical costs, indirect medical costs, disability, work loss, and premature death. These factors only include the diagnosed cases of the disease. There are millions more people living with the condition yet haven’t been diagnosed, while others are treating the symptoms of pre-diabetes and gestational diabetes. The costs of treating these groups came to about $218 billion in 2007.
So, if we see the staggering costs of this disease, what can be done? First, it’s important to note the major differences between the two types of diabetes. Dr. Josh Umbehr of Altas.MD broke down the differences to the very basic level. (more…)
There have been many speculations as to the cause of Alzheimer’s disease, the most common form of dementia. Currently, there is no cure for the condition and as it progresses it worsens, often causing memory loss, mood swings, aggression and confusion, and eventually leading to death.
Though Alzheimer’s was formerly thought to be a disease of age, a growing body of research now suggests that it may be a metabolic disease – linking it to poor diet. As reported by the Guardian, scientists have even gone so far as to call it type 3 diabetes.
This news is especially concerning as Alzheimer’s currently affects an estimated 35 million people worldwide, and that number is expected to reach 100 million by 2050. Equally alarming are projected growth rates of type 2 diabetes in the U.S. alone, which are also expected to triple in the next several decades.
These speculations are tied to two potential factors: 1) Alzheimer’s causes a lack of natural insulin in the body, or 2) it causes an impairment of the brain’s ability to respond it. Suspicions of the link continue to rise as those who die from Alzheimer’s are often found to have low insulin levels in the brain. This has led researchers to believe that insulin is produced in the brain as well as in the pancreas, explaining why it could play such a crucial role in neuron signaling and cell growth and lifespan, according to Popsci. (more…)
The Centers for Disease Control and Prevention released new frightening statistics for the obesity rates across the country. Obesity rates in America are climbing rapidly, with an estimated 35.7% of the adult population classified as such. The South has the highest obesity rate and the Midwest is right behind them. Citizens living in Northeast and West have the lowest obesity rates.
As reported by BizJournal.com, Massachusetts is the third lowest obesity rate state. However, Massachusetts should not celebrate their bronze medal in these results. Massachusetts may have a low obesity rate compared to 47 states, but that does not mean there isn’t a problem internally with the state. One-third of Massachusetts children and two-thirds of the adult population are either obese or overweight.
Cheryl Bartlett, director of the Massachusetts Bureau of Community Health and Prevention, speaks out on the state’s health issue. “On a national level, (Massachusetts) looks pretty good. But we’ve got a long way to go.” Bartlett and her organization have a goal for the state of Massachusetts. They want to see obesity levels decrease by 5% within the next 15 years. Plus, a reduction in type 2 diabetes and high cholesterol cases. However, no specific plan to reach that was shared. (more…)
MyNetDiary – one of the top diet apps available to smart phone users – launched a new online and mobile app called Diabetes Tracker that’s specifically designed to help those with diabetes better manage their condition.
Launched in 2007 and now hosting more than 2.5 million members, MyNetDiary wanted to bring a diabetes-friendly app to the market since it’s a disease affecting nearly 26 million people in the U.S. alone.
Sergey Oresko, CEO of MyNetDiary, said in a press release that since launching their initial diet app, the company has received a number of requests for an app that caters specifically to diabetics.
“We’ve been asked by thousands of our members to help them track their battle with diabetes,” he said. “And after a year of work on this, we’re pleased to offer the most user-friendly and easy app for tracking everything related to diabetes, diet and exercise, all wrapped into a single iPhone app.”
We recently chatted with Ryan Newhouse, MyNetDiary marketing director, to get a better understanding of how the app works. First, he explained that the Diabetes Tracker is an educational tool and is not intended to diagnose, treat or cure any ailment or disease. (more…)